Mark N. Lampert just provided an update on share ownership of Corvus Pharmaceuticals, Inc.

Mark N. Lampert just filed a "Statement of acquisition of beneficial ownership", which is also known as a 13G. In the filing, it appears as though Mark N. Lampert claims to own 1,559,939 shares. This represents 5.4% of Corvus Pharmaceuticals, Inc..

Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.

To receive a free e-mail notification whenever Corvus Pharmaceuticals, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

On September - Sept. 17, 2020
Corvus Pharmaceuticals, Inc. director was just granted 30,000 options - Sept. 15, 2020
Corvus Pharmaceuticals, Inc. director just declared 0 ownership of the company. - Sept. 15, 2020
Departure of Directors or Certain - Sept. 11, 2020
On September - Sept. 10, 2020

Auto Refresh

Feedback